Abnoll Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.44 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Revenue Growth 111.20%
- Profit Growth 518.95%
- Ebitda 2065.86%
- Net Worth 341.81%
- Total Assets 65.76%
About Abnoll Healthcare
Abnoll Healthcare Private Limited (AHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 April 2011 and has a history of 13 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.44 M.
The company currently has active open charges totaling ₹1.00 Cr.
Pankaj Gupta and Keshav Garg serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232DL2011PTC217998
- Company No.
217998
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Abnoll Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pankaj Gupta  | Director | 06-Dec-2021 | Current |
| Keshav Garg | Director | 21-Dec-2018 | Current |
Financial Performance of Abnoll Healthcare.
Abnoll Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 111.2% increase. The company also saw a substantial improvement in profitability, with a 518.95% increase in profit. The company's net worth Soared by an impressive increase of 341.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abnoll Healthcare?
In 2023, Abnoll Healthcare had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charchika Enterprises Private LimitedPankaj Gupta and Keshav Garg are mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jan 2023 | Hdfc Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Abnoll Healthcare?
Unlock and access historical data on people associated with Abnoll Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abnoll Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abnoll Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
